BRPI0922844A2 - peptídeos de epítopo de wdrpuh e vacinas contendo os mesmos - Google Patents

peptídeos de epítopo de wdrpuh e vacinas contendo os mesmos

Info

Publication number: BRPI0922844A2
Authority: BR; Brazil
Prior art keywords: same; epitope peptides; vaccines containing; wdrpuh; wdrpuh epitope
Prior art date: 2008-12-05

Application number

BRPI0922844A

Other languages

English (en)

Inventor

Ryuji Ohsawa

Sachiko Yoshimura

Takuya Tsunoda

Tomohisa Watanabe

Original Assignee

Oncotherapy Science Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-12-05

Filing date

2009-12-03

Publication date

2015-12-29

2009-12-03 Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc

2015-12-29 Publication of BRPI0922844A2 publication Critical patent/BRPI0922844A2/pt

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/42—Cancer antigens
- A61K40/4202—Receptors, cell surface antigens or cell surface determinants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
- C12N5/0638—Cytotoxic T lymphocytes [CTL] or lymphokine activated killer cells [LAK]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/11—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from blood or immune system cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Biomedical Technology (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Wood Science & Technology (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Microbiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Pharmacology & Pharmacy (AREA)
Cell Biology (AREA)
Hematology (AREA)
General Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Oncology (AREA)
Mycology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BRPI0922844A 2008-12-05 2009-12-03 peptídeos de epítopo de wdrpuh e vacinas contendo os mesmos BRPI0922844A2 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US20096208P	2008-12-05	2008-12-05
US20970409P	2009-03-09	2009-03-09
PCT/JP2009/006573 WO2010064430A1 (en)	2008-12-05	2009-12-03	Wdrpuh epitope peptides and vaccines containing the same

Publications (1)

Publication Number	Publication Date
BRPI0922844A2 true BRPI0922844A2 (pt)	2015-12-29

Family

ID=42233088

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0922844A BRPI0922844A2 (pt)	2008-12-05	2009-12-03	peptídeos de epítopo de wdrpuh e vacinas contendo os mesmos

Country Status (18)

Country	Link
US (3)	US8541546B2 (pt)
EP (3)	EP2370454A4 (pt)
JP (1)	JP5764823B2 (pt)
KR (1)	KR101705102B1 (pt)
CN (2)	CN102307891B (pt)
AU (1)	AU2009323523B2 (pt)
BR (1)	BRPI0922844A2 (pt)
CA (2)	CA3031126C (pt)
DK (1)	DK3219720T3 (pt)
ES (1)	ES2913148T3 (pt)
IL (2)	IL212945B (pt)
MX (1)	MX2011005944A (pt)
NZ (2)	NZ593086A (pt)
RU (1)	RU2514386C2 (pt)
SG (1)	SG171977A1 (pt)
TW (2)	TWI500932B (pt)
WO (1)	WO2010064430A1 (pt)
ZA (1)	ZA201104890B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20150359864A1 (en)	2012-03-09	2015-12-17	Oncotherapy Science, Inc.	Pharmaceutical composition containing peptides
JP6283861B2 (ja)	2012-09-11	2018-02-28	オンコセラピー・サイエンス株式会社	Ｕｂｅ２ｔペプチドおよびそれを含むワクチン

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4722848A (en)	1982-12-08	1988-02-02	Health Research, Incorporated	Method for immunizing animals with synthetically modified vaccinia virus
US5703055A (en)	1989-03-21	1997-12-30	Wisconsin Alumni Research Foundation	Generation of antibodies through lipid mediated DNA delivery
US5804566A (en)	1993-08-26	1998-09-08	The Regents Of The University Of California	Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides
US5679647A (en)	1993-08-26	1997-10-21	The Regents Of The University Of California	Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
US5739118A (en)	1994-04-01	1998-04-14	Apollon, Inc.	Compositions and methods for delivery of genetic material
US5736524A (en)	1994-11-14	1998-04-07	Merck & Co.,. Inc.	Polynucleotide tuberculosis vaccine
US5922687A (en)	1995-05-04	1999-07-13	Board Of Trustees Of The Leland Stanford Junior University	Intracellular delivery of nucleic acids using pressure
CA2225553A1 (en)	1995-08-03	1997-02-20	Rijksuniversiteit Te Leiden	Cell derived antigen presenting vesicles
US5853719A (en)	1996-04-30	1998-12-29	Duke University	Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
WO1998004720A1 (en)	1996-07-26	1998-02-05	Sloan-Kettering Institute For Cancer Research	Method and reagents for genetic immunization
FR2766205B1 (fr)	1997-07-16	2002-08-30	Inst Nat Sante Rech Med	Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede
WO1999067288A1 (en)	1998-06-25	1999-12-29	Sumitomo Pharmaceuticals Company, Limited	Tumor antigen peptides originating in cyclophilin b
SI1513934T1 (sl)	2002-06-06	2011-06-30	Oncotherapy Science Inc	Geni in polipeptidi, povezani s humanimi raki kolona
SG145559A1 (en)	2002-06-06	2008-09-29	Oncotherapy Science Inc	Genes and polypeptides relating to human colon cancers
DK2261249T3 (en) *	2002-09-12	2015-02-16	Oncotherapy Science Inc	KDR peptides and vaccines comprising the same
WO2006031221A1 (en)	2004-09-13	2006-03-23	Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services	Compositions comprising t cell receptors and methods of use thereof
PL2325306T3 (pl)	2005-02-25	2014-07-31	Oncotherapy Science Inc	Szczepionki peptydowe do zastosowania w nowotworach płuc, wykazujących ekspresję polipeptydów TTK, URLC10 lub KOC1
CN101287831B (zh)	2005-09-13	2013-05-15	国立大学法人三重大学	T细胞受体和编码该受体的核酸
TWI615403B (zh) *	2007-02-21	2018-02-21	腫瘤療法科學股份有限公司	表現腫瘤相關抗原之癌症的胜肽疫苗
TW201425333A (zh)	2007-04-11	2014-07-01	Oncotherapy Science Inc	腫瘤血管內皮標誌８胜肽及包含此胜肽之疫苗
TW201008574A (en)	2008-08-19	2010-03-01	Oncotherapy Science Inc	INHBB epitope peptides and vaccines containing the same

2009
- 2009-12-02 TW TW098141123A patent/TWI500932B/zh not_active IP Right Cessation
- 2009-12-02 TW TW103140741A patent/TWI539160B/zh not_active IP Right Cessation
- 2009-12-03 SG SG2011041043A patent/SG171977A1/en unknown
- 2009-12-03 WO PCT/JP2009/006573 patent/WO2010064430A1/en not_active Ceased
- 2009-12-03 BR BRPI0922844A patent/BRPI0922844A2/pt not_active IP Right Cessation
- 2009-12-03 CN CN200980156195.6A patent/CN102307891B/zh active Active
- 2009-12-03 ES ES17167553T patent/ES2913148T3/es active Active
- 2009-12-03 CA CA3031126A patent/CA3031126C/en active Active
- 2009-12-03 EP EP09830200.3A patent/EP2370454A4/en not_active Withdrawn
- 2009-12-03 AU AU2009323523A patent/AU2009323523B2/en not_active Ceased
- 2009-12-03 CN CN201410851691.6A patent/CN104650183B/zh active Active
- 2009-12-03 EP EP22158260.4A patent/EP4047009A3/en active Pending
- 2009-12-03 US US13/132,891 patent/US8541546B2/en active Active
- 2009-12-03 JP JP2011524084A patent/JP5764823B2/ja active Active
- 2009-12-03 EP EP17167553.1A patent/EP3219720B1/en active Active
- 2009-12-03 RU RU2011127429/04A patent/RU2514386C2/ru active
- 2009-12-03 KR KR1020117014316A patent/KR101705102B1/ko not_active Expired - Fee Related
- 2009-12-03 NZ NZ593086A patent/NZ593086A/xx not_active IP Right Cessation
- 2009-12-03 CA CA2745408A patent/CA2745408C/en active Active
- 2009-12-03 MX MX2011005944A patent/MX2011005944A/es active IP Right Grant
- 2009-12-03 NZ NZ605799A patent/NZ605799A/en not_active IP Right Cessation
- 2009-12-03 DK DK17167553.1T patent/DK3219720T3/da active
2011
- 2011-05-17 IL IL212945A patent/IL212945B/en active IP Right Grant
- 2011-07-04 ZA ZA2011/04890A patent/ZA201104890B/en unknown
2013
- 2013-05-23 US US13/900,720 patent/US9115207B2/en active Active
- 2013-09-03 IL IL228266A patent/IL228266A/en active IP Right Grant
2015
- 2015-07-21 US US14/805,424 patent/US9745343B2/en active Active

Also Published As

Publication number	Publication date
CA3031126A1 (en)	2010-06-10
CN104650183B (zh)	2018-04-20
US20110293645A1 (en)	2011-12-01
JP5764823B2 (ja)	2015-08-19
US9745343B2 (en)	2017-08-29
CN104650183A (zh)	2015-05-27
TWI500932B (zh)	2015-09-21
IL212945A0 (en)	2011-07-31
NZ593086A (en)	2013-02-22
CN102307891A (zh)	2012-01-04
ES2913148T3 (es)	2022-05-31
SG171977A1 (en)	2011-07-28
KR101705102B1 (ko)	2017-02-22
CN102307891B (zh)	2015-02-04
MX2011005944A (es)	2011-07-28
IL228266A (en)	2016-09-29
ZA201104890B (en)	2012-03-28
DK3219720T3 (da)	2022-05-09
US9115207B2 (en)	2015-08-25
RU2011127429A (ru)	2013-01-10
US8541546B2 (en)	2013-09-24
WO2010064430A1 (en)	2010-06-10
JP2012510794A (ja)	2012-05-17
RU2514386C2 (ru)	2014-04-27
NZ605799A (en)	2014-03-28
CA3031126C (en)	2022-03-22
CA2745408A1 (en)	2010-06-10
IL212945B (en)	2018-03-29
CA2745408C (en)	2019-03-12
US20130315942A1 (en)	2013-11-28
AU2009323523B2 (en)	2016-08-11
EP2370454A4 (en)	2013-11-20
TWI539160B (zh)	2016-06-21
AU2009323523A1 (en)	2010-06-10
EP3219720A3 (en)	2018-01-03
TW201027074A (en)	2010-07-16
EP3219720A2 (en)	2017-09-20
TW201510529A (zh)	2015-03-16
EP4047009A2 (en)	2022-08-24
EP4047009A3 (en)	2022-11-16
EP2370454A1 (en)	2011-10-05
EP3219720B1 (en)	2022-03-09
KR20110099018A (ko)	2011-09-05
US20150315239A1 (en)	2015-11-05

Legal Events

Date	Code	Title	Description
2018-01-23	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2019-12-17	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2020-02-27	B06U	Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
2020-10-06	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2021-04-20	B09B	Patent application refused [chapter 9.2 patent gazette]
2021-06-22	B12B	Appeal against refusal [chapter 12.2 patent gazette]
2023-09-26	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 14A ANUIDADE.
2024-01-16	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2751 DE 26/09/2023.

Publication	Publication Date	Title
BRPI0914782A2 (pt)	2016-07-26	peptídeos de epítopos de cdca1 e vacinas contendo os mesmos
BRPI1008887A2 (pt)	2016-03-01	peptídeos de foxm1 e vacinas contendo os mesmo
IL211131A0 (en)	2011-04-28	Inhbb epitope and vaccines containing the same
PL2465864T3 (pl)	2015-03-31	Szczepionki z peptydem pochodzącym z Eph4
EP2318438A4 (en)	2012-11-21	ANTI-P2X7 PEPTIDES AND EPITOPES
BRPI0811021A2 (pt)	2014-10-21	Peptídeos e vacinas de tem8 compreendendo os mesmos
BRPI0917391A2 (pt)	2015-12-01	peptídeo de epítodo de hig2 e urlc10 e vacinas contendo o mesmo
IL209869A0 (en)	2011-02-28	Iqgap3 epitope peptides and vaccines containing the same
IL232461A0 (en)	2014-06-30	Melk epitope peptides and vaccines containing the same
IL229926A (en)	2016-11-30	Neil3 peptides and vaccines including the same
IL209870A0 (en)	2011-02-28	Mybl2 epitope peptides and vaccines containing the same
BRPI0919766A2 (pt)	2017-03-21	peptídeo de epítopo de rab6kifl/kif20a e vacinas contendo o mesmo
BRPI1012312A2 (pt)	2017-03-21	peptídeos vangl1 e vacinas incluindo os mesmos
BRPI1010666A2 (pt)	2017-09-12	peptídeos de cdc45l e vacinas incluindo dos mesmos
BRPI1013938A2 (pt)	2019-09-24	"peptídeos ttk e vacinas incluindo os mesmos"
BR112013013158A2 (pt)	2017-08-01	peptídeos de tomm34 e vacinas incluindo os mesmos
BRPI0923402A2 (pt)	2015-08-04	Peptídeos c10rf59 e vacinas incluindo os mesmos.
BR112012002311A2 (pt)	2016-05-31	composto, composição farmacêutica, e, uso do composto.
BRPI1013384A2 (pt)	2016-03-29	peptídeos c6orf167 e vacinas incluindo os mesmos
ZA201207342B (en)	2013-06-26	Ect2 peptides and vaccines including the same
IL212945B (en)	2018-03-29	Wdrpuh epitope peptides and vaccines containing the same
TH0901004695A (th)	2015-05-29	Rab6kifl/kif20a อิพิโทป เปปไทด์ และ วัคซีนที่ ประกอบด้วยสิ่งเดียวกันนั้น
HK1162528A (en)	2012-08-31	Wdrpuh epitope peptides and vaccines containing the same
HK1176365A (en)	2013-07-26	Modified melk peptides and vaccines containing the same
HK1155755A (en)	2012-05-25	Iqgap3 epitope peptides and vaccines containing the same